A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

NCT07681479 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Fluid Retention Due to Heart Failure

Interventions

DRUG: [14C]HRS-9057

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.